Skip to content
value.today

Onesource Specialty Pharma Limited

ONESOURCE.NS
$2.0 Bmarket cap on Nov 19, 2026
1D
+1.2%
Compare
World rank
#6,399
Revenue
—
annual
Net income
—
Employees
—

Onesource Specialty Pharma Limited in brief

Onesource Specialty Pharma Limited is a listed company in the Healthcare sector, based in India. Its market value was $2.0 B on 19 November 2026, which makes it the 6,399th largest listed company in the world and the 395th largest in India on this site. Its shares trade under the symbol ONESOURCE.NS (NSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Onesource Specialty Pharma Limited timeline

1 events, 2025
  1. 2025
  2. 📈
    Listed on National Stock Exchange of India as ONESOURCE
    First day of listing in the exchange's official list.

Events of Onesource Specialty Pharma Limited from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Onesource Specialty Pharma Limited share price · NSE (ONESOURCE.NS)

daily · 448 trading days since 2025
Last close 1,603 INR (Nov 19, 2026)1 month: +17.3%1 year: -5.9%52-week range 1,057 – 1,918 INR
$0 M$593 M$1.2 B$1.8 B$2.4 B2026
DateOpenHighLowCloseChangeVolume
Nov 19, 20261,5871,6171,5701,603+1.1%126,006
Nov 18, 20261,5811,5921,5631,586+0.3%159,423
Nov 17, 20261,6121,6141,5781,581-2.0%210,366
Nov 16, 20261,6151,6501,5881,613+0.2%311,345
Nov 13, 20261,6201,6881,6011,610-0.6%599,203
Nov 12, 20261,5831,6351,5771,620+2.4%277,501
Nov 11, 20261,6211,6441,5771,582-2.2%221,763
Nov 9, 20261,6251,6501,6101,618+1.1%165,587
Nov 6, 20261,5821,6191,5661,600+1.1%276,774
Nov 5, 20261,6101,6441,5701,582-0.1%654,875
Nov 4, 20261,5851,6001,5661,584+0.9%481,453
Nov 3, 20261,5691,5751,5361,569+0.7%318,991
Nov 2, 20261,5631,6021,5421,558-0.3%329,034
Oct 30, 20261,5751,6001,5411,563-0.4%954,663
Oct 29, 20261,5851,5981,5641,570-0.5%736,956
Oct 28, 20261,6201,6431,5601,578-0.8%3.8 M
Oct 27, 20261,4031,6051,3841,590+13.8%7.8 M
Oct 26, 20261,3341,4051,3261,397+4.7%228,373
Oct 23, 20261,3781,3781,3211,334-3.2%206,529
Oct 22, 20261,3581,3851,3261,378+1.5%108,051
Oct 21, 20261,3661,3851,3311,357-0.7%216,713
Oct 19, 20261,4131,4131,3521,367-2.9%92,387
Oct 16, 20261,4481,4481,4021,408-1.8%103,563
Oct 15, 20261,4401,4421,4211,433-0.6%85,979
Oct 14, 20261,4591,4601,4241,442-1.1%303,380
Oct 13, 20261,4691,4781,4351,459-0.8%228,818
Oct 12, 20261,4611,5041,4431,471+0.7%167,234
Oct 9, 20261,4791,4911,4381,461-1.1%194,585
Oct 8, 20261,5281,5351,4631,478-3.3%232,650
Oct 7, 20261,5291,5481,5111,529—101,988

Prices in INR from the National Stock Exchange of India; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.

Onesource Specialty Pharma Limited share price statistics

computed nightly from the daily prices
NSE · ONESOURCE.NSClose 1,603 INR (Nov 19, 2026)
1 day
+1.1%
1 week
-1.1%
1 month
+17.3%
3 months
+5.4%
Year to date
-11.5%
1 year
-5.9%
3 years
—
5 years
—
10 years
—
52-week low 1,057-16.4% from the highhigh 1,918
Highest on record 2,248 INR (Jun 18, 2025)Volume 656,985 shares/dayValue traded 1.03 B INR/dayVolatility 46% (30d), 45% (1y)448 trading days on record

Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.

Market cap history

$0 M$533 M$1.1 B$1.6 B$2.1 B

World rank over time

▲ up 33 places since 2026
2026-11-12: #6433#6,43320262026-11-13: #6487#6,48720262026-11-16: #6409#6,40920262026-11-17: #6486#6,48620262026-11-18: #6467#6,46720262026-11-19: #6400#6,4002026

Rank in India: #390 (Nov 2026) · #395 (Nov 2026) · #392 (Nov 2026) · #397 (Nov 2026) · #394 (Nov 2026) · #395 (Nov 2026)

Mutual funds holding Onesource Specialty Pharma Limited#

46 funds in 2 countries hold shares worth $249 M. Since their previous reports 18 added shares and 22 sold, selling $5 M net. By country: India 22 ($153 M), USA 24 ($97 M).
Mutual funds holding Onesource Specialty Pharma Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇮🇳 Motilal Oswal Large and Midcap FundMotilal Oswal Asset Management3.84 M$63 M—3.0%+3.1%Oct 31, 2026
🇮🇳 Motilal Oswal Flexicap FundMotilal Oswal Asset Management2.47 M$41 M—2.9%+3.4%Oct 31, 2026
🇺🇸 Fidelity Blue Chip Growth FundFidelity Management & Research Company LLC2.02 M$34 M—0.03%no changeJul 31, 2026
🇮🇳 Motilal Oswal ELSS Tax Saver FundMotilal Oswal Asset Management1.09 M$18 M—3.6%no changeOct 31, 2026
🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc.732,216$12 M—<0.01%−5.0%Jul 31, 2026
🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc.689,229$12 M—<0.01%no changeJul 31, 2026
🇺🇸 iShares Core MSCI Emerging Markets ETFBlackRock Fund Advisors551,156$11 M—<0.01%+1.3%May 31, 2026
🇮🇳 Aditya Birla Sun Life Flexi Cap FundAditya Birla Sun Life AMC485,952$8 M—0.27%no changeOct 31, 2026
🇮🇳 Aditya Birla Sun Life Value FundAditya Birla Sun Life AMC440,404$7 M—1.1%no changeOct 31, 2026
🇺🇸 Fidelity Blue Chip Growth K6 FundFidelity Management & Research Company LLC414,000$7 M—0.03%no changeJul 31, 2026
🇺🇸 Fidelity Series Blue Chip Growth FundFidelity Management & Research Company LLC373,400$6 M—0.04%no changeJul 31, 2026
🇮🇳 Motilal Oswal Active Momentum FundMotilal Oswal Asset Management244,150$4 M—2.6%no changeOct 31, 2026
🇺🇸 Vanguard Ftse All-World Ex-Us Small-Cap Index FundThe Vanguard Group, Inc.194,252$3 M—0.02%+8.7%Jul 31, 2026
🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc.156,983$3 M—0.02%no changeJun 30, 2026
🇮🇳 Motilal Oswal Small Cap FundMotilal Oswal Asset Management152,251$3 M—0.29%−70%Oct 31, 2026
🇮🇳 Nippon India Nifty Smallcap 250 Index FundNippon Life India Asset Management116,885$2 M—0.58%−4.0%Oct 31, 2026
🇺🇸 iShares Core MSCI Total International Stock ETFBlackRock Fund Advisors110,204$2 M—<0.01%+1.3%Jul 31, 2026
🇺🇸 Avantis Emerging Markets Equity ETFAmerican Century ETF Trust96,404$2 M—<0.01%no changeMay 31, 2026
🇺🇸 iShares MSCI India Small-Cap ETFBlackRock Fund Advisors81,952$2 M—0.25%−6.2%May 31, 2026
🇮🇳 Aditya Birla Sun Life Special Opportunities FundAditya Birla Sun Life AMC87,060$1 M—1.0%+53%Oct 31, 2026
🇮🇳 SBI Nifty Smallcap 250 Index FundSBI Funds Management62,262$1 M—0.58%+0.7%Oct 31, 2026
🇮🇳 Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla Sun Life AMC60,000$1 M—0.86%newOct 31, 2026
🇮🇳 Aditya Birla Sun Life Manufacturing Equity FundAditya Birla Sun Life AMC59,397$1 M—0.70%no changeOct 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.44,645$1 M—<0.01%no changeJul 31, 2026
🇮🇳 Motilal Oswal Nifty Smallcap 250 Index FundMotilal Oswal Asset Management43,871$1 M—0.58%+0.0%Oct 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC39,840$1 M—<0.01%+22%Jun 30, 2026
🇺🇸 Fidelity Total International Index FundFidelity Management & Research Company LLC35,543$1 M—<0.01%+21%Jul 31, 2026
🇮🇳 Nsmall50Aditya Birla Sun Life AMC30,867$1 M—1.5%−8.5%Oct 31, 2026
🇮🇳 Tata Nifty Midsmall Healthcare Index FundTata Asset Management28,574$0 M—1.9%+7.2%Oct 31, 2026
🇮🇳 Motilal Oswal Special Opportunities FundMotilal Oswal Asset Management23,327$0 M—3.0%no changeOct 31, 2026
🇺🇸 iShares MSCI Emerging Markets Small-Cap ETFBlackRock Fund Advisors12,528$0 M—0.06%no changeMay 31, 2026
🇺🇸 State Street Global All Cap Equity ex-U.S. Index PortfolioSSGA Funds Management, Inc.13,121$0 M—<0.01%no changeJun 30, 2026
🇮🇳 Motilal Oswal Nifty 500 Index FundMotilal Oswal Asset Management12,913$0 M—0.06%+2.0%Oct 31, 2026
🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc.10,833$0 M—<0.01%−31%May 31, 2026
🇺🇸 Avantis Emerging Markets Value ETFAmerican Century ETF Trust7,814$0 M—0.01%no changeMay 31, 2026
🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc.8,307$0 M—0.03%+7.7%Jun 30, 2026
🇮🇳 Motilal Oswal Nifty Smallcap 250 ETFMotilal Oswal Asset Management8,720$0 M—0.58%−1.4%Oct 31, 2026
🇮🇳 Nippon India Nifty 500 Equal Weight Index FundNippon Life India Asset Management5,793$0 M—0.21%+0.7%Oct 31, 2026
🇮🇳 Tata Nifty500 Multicap India Manufacturing 50-30-20 Index FundTata Asset Management4,290$0 M—0.49%+6.5%Oct 31, 2026
🇺🇸 State Street SPDR Portfolio MSCI Global Stock Market ETFSSGA Funds Management, Inc.3,817$0 M—<0.01%+13%Jun 30, 2026
🇮🇳 SBI Nifty 500 Index FundSBI Funds Management3,056$0 M—0.06%+1.6%Oct 31, 2026
🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust1,868$0 M—0.02%−5.6%May 31, 2026
🇮🇳 Motilal Oswal Nifty 500 ETFMotilal Oswal Asset Management1,225$0 M—0.06%no changeOct 31, 2026
🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust1,049$0 M—0.02%no changeMay 31, 2026
🇺🇸 Avantis Emerging Markets ex-China Equity ETFAmerican Century ETF Trust938$0 M—<0.01%no changeMay 31, 2026
🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP3$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Oct 31, 2026. The 46 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Where Onesource Specialty Pharma Limited operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Onesource Specialty Pharma Limited: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Onesource Specialty Pharma Limited: countries of operation
CountryPresenceRevenue there
🇮🇳 IndiaHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

FDA drug approvals: Onesource Specialty Pharma Limited#

46 approved applications held; 1 approvals and 0 new uses in 2025.

Approvals held
46
New molecular entities
0
New uses approved
0
efficacy supplements
Generics
45
1 new drugs, 0 biologics
Onesource Specialty Pharma Limited: latest FDA approvals
ApprovedDrugKind
2025-03-05Levothyroxine SodiumLevothyroxine Sodium · ANDA216729Generic drug (ANDA)
2024-11-21Sumatriptan SuccinateSumatriptan Succinate · ANDA215651Generic drug (ANDA)
2024-10-29Thiamine HydrochlorideThiamine Hydrochloride · ANDA217181Generic drug (ANDA)
2024-10-03Methohexital SodiumMethohexital Sodium · ANDA215488Generic drug (ANDA)
2023-09-22Icosapent EthylIcosapent Ethyl · ANDA217844Generic drug (ANDA)
2023-07-25Carboprost TromethamineCarboprost Tromethamine · ANDA216897Generic drug (ANDA)
2023-04-19AcetylcysteineAcetylcysteine · ANDA217182Generic drug (ANDA)
2022-12-23Mycophenolate Mofetil HydrochlorideMycophenolate Mofetil Hydrochloride · ANDA216390Generic drug (ANDA)
2022-08-17Naproxen SodiumNaproxen Sodium · ANDA215472Generic drug (ANDA)
2022-08-02CyclosporineCyclosporine · ANDA216046Generic drug (ANDA)
2022-02-18Amantadine HydrochlorideAmantadine Hydrochloride · ANDA211354Generic drug (ANDA)
2021-08-11Loperamide HydrochlorideLoperamide Hydrochloride · ANDA213070Generic drug (ANDA)
2020-01-15LoratadineLoratadine · ANDA211926Generic drug (ANDA)
2019-12-03Diclofenac PotassiumDiclofenac Potassium · ANDA210078Generic drug (ANDA)
2019-02-19EthosuximideEthosuximide · ANDA211928Generic drug (ANDA)
2018-03-28IbuprofenIbuprofen · ANDA204469Generic drug (ANDA)
2017-11-17Ganciclovir SodiumGanciclovir Sodium · ANDA204560Generic drug (ANDA)
2017-09-19Omega-3-Acid Ethyl EstersOmega-3-Acid Ethyl Esters · ANDA203893Generic drug (ANDA)
2017-07-21Cetirizine Hydrochloride AllergyCetirizine Hydrochloride · ANDA205291Generic drug (ANDA)
2015-11-20DutasterideDutasteride · ANDA204262Generic drug (ANDA)
2015-07-30BenzonatateBenzonatate · ANDA091133Generic drug (ANDA)
2014-12-12CalcitriolCalcitriol · ANDA091356Generic drug (ANDA)
2014-08-25Oxacillin SodiumOxacillin Sodium · ANDA091486Generic drug (ANDA)
2014-08-15Piperacillin And TazobactamPiperacillin Sodium, Tazobactam Sodium · ANDA065458Generic drug (ANDA)
2014-08-04Ketorolac TromethamineKetorolac Tromethamine · ANDA201155Generic drug (ANDA)

Source: Drugs@FDA (openFDA). Approvals are listed under the application's current holder (ONESOURCE SPECIALTY and ONESOURCE), so they follow acquisitions

Product recalls by Onesource Specialty Pharma Limited#

1 recalls since 2015, 4,284 units in the notices that give a number. Drugs (FDA): 1.

Onesource Specialty Pharma Limited: product recalls
DateWhat and whyUnitsNotice
Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru - 561 203, India, Manufactured for: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-893-31Failed Impurities/Degradation SpecificationsDrugsClass II4,284D-0662-2026

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

Discuss Onesource Specialty Pharma Limited#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 46 funds hold $249 millionautomatic update · Oct 31, 2026

    46 mutual funds in 2 countries hold shares of Onesource Specialty Pharma Limited worth $249 million (funds' newest reports, up to 31 October 2026). Since their previous reports 18 funds added shares and 22 sold; on balance they sold $5 million. Share splits are not counted as trading.

How Onesource Specialty Pharma Limited compares in Healthcare

CompanyMarket capP/ENet marginRev. growth
Onesource Specialty Pharma Limited🇮🇳$2.0 B———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Nov 19, 2026
Profile updated:
Nov 20, 2026

Figures from Market data, value.today research, GLEIF register.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Onesource Specialty Pharma Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Onesource Specialty Pharma Limited's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Onesource Specialty Pharma Limited? Suggest a correction